{
    "organizations": [],
    "uuid": "e06746cfb377cb36fad2e4123ddba1538ca5cc04",
    "author": "Joseph Walker",
    "url": "https://www.wsj.com/articles/rivals-help-fund-regenerons-gene-sequencing-effort-1515412800",
    "ord_in_thread": 0,
    "title": "Rivals Help Fund Regeneron’s Gene-Sequencing Effort",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Some of the world’s largest pharmaceutical companies are pooling resources to fund an ambitious genetic and medical database aimed at bolstering the search for new drugs.\nAbbVie Inc., Alnylam Pharmaceuticals Inc., AstraZeneca PLC, Biogen Inc. and Pfizer Inc. will pay $10 million each to Regeneron Pharmaceuticals Inc., which began the project last year in partnership with the U.K. Biobank, a nonprofit that has collected DNA samples and health records from half a million people in the U.K., and drugmaker GlaxoSmithKline PLC.\n... ",
    "published": "2018-01-08T14:00:00.000+02:00",
    "crawled": "2018-01-09T09:40:24.074+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "world",
        "largest",
        "pharmaceutical",
        "company",
        "pooling",
        "resource",
        "fund",
        "ambitious",
        "genetic",
        "medical",
        "database",
        "aimed",
        "bolstering",
        "search",
        "new",
        "drug",
        "abbvie",
        "alnylam",
        "pharmaceutical",
        "astrazeneca",
        "plc",
        "biogen",
        "pfizer",
        "pay",
        "million",
        "regeneron",
        "pharmaceutical",
        "began",
        "project",
        "last",
        "year",
        "partnership",
        "biobank",
        "nonprofit",
        "collected",
        "dna",
        "sample",
        "health",
        "record",
        "half",
        "million",
        "people",
        "drugmaker",
        "glaxosmithkline",
        "plc"
    ]
}